Effect of steroids on the activation status of platelets in patients with Immune thrombocytopenia (ITP)

References

• McMillan R, Tani P, Millard F, Berchtold P, Renshow L, Woods VL Jr. Platelet-associated and plasma anti-glycoprotein autoantibodies in chronic ITP. Blood 1987;70:1040–1045
   PubMed Web of Science ®Google Scholar
• Fujisawa K, O'Toole TE, Tani P, Loftus JC, Plow EF, Ginsberg MH, McMillan R. Autoantibodies to the presumptive cytoplasmic domain of platelet glycoprotein IIIa in patients with chronic immune thrombocytopenic purpura. Blood 1991;77:2207–2213
   PubMed Web of Science ®Google Scholar
• Fujisawa K, Tani P, O'Toole TE, Ginsberg MH, McMillan R. Different specificities of platelet-associated and plasma autoantibodies to platelet GPIIb-IIIa in patients with chronic immune thrombocytopenic purpura. Blood 1992;79:1441–1446
   PubMed Web of Science ®Google Scholar
• Phillips DR, Charo IF, Scarborough RM. GPIIb-IIIa: The responsive integrin. Cell 1991;65:359–362
   PubMed Web of Science ®Google Scholar
• Coller BS, Shattil SJ. GPIIb/IIIa (Intergrin αIIbβ3) odyssey: A technology driven saga of twists, turns and even a bend. Blood 2008;112:3011–3025
   PubMed Web of Science ®Google Scholar
• Kosugi S, Tomiyama Y, Honda S. Platelet-associated anti–GPIIb-IIIa autoantibodies in chronic immune thrombocytopenic purpura recognizing epitopes close to the ligand-binding site of glycoprotein (GP) IIb. Blood 2001;98:1819–1827
   Google Scholar
• Kiefel V, Santoso S, Kaufmann E, Mueller-Eckhardt C. Autoantibodies against platelet glycoprotein Ib/IX: A frequent finding in autoimmune thrombocytopenic purpura. Br J Haematol 1991;79:256–262
   PubMed Web of Science ®Google Scholar
• Semple JW, Provan D, Garvey MB, Freedman J. Recent progress in understanding the pathogenesis of immune thrombocytopenia. Curr Opin Hematol 2010;17:590–595
   PubMed Web of Science ®Google Scholar
• Johnsen J. Pathogenesis in immune thrombocytopenia: New insights. Hematology Am Soc Hematol Educ Program 2012;2012:306–312
   PubMed Web of Science ®Google Scholar
• Stenberg PE, McEver RP, Shuman MA, Jacques YV, Bainton DF. A platelet alpha-granule membrane protein (GMP-140) is expressed on the plasma membrane after activation. J Cell Biol 1985;101:880–886
   PubMed Web of Science ®Google Scholar
• Shattil SJ, Hoxie JA, Cunningham M, Brass LF. Changes in the platelet membrane glycoprotein IIb/IIIa complex during platelet activation. J Biol Chem 1985;260:11107–11114
   PubMed Web of Science ®Google Scholar
• Neunert C, Lim W, Crowther M, Cohen A, Solberg L Jr, Crowther MA. The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia. Blood 2011;117:4190–4207
   PubMed Web of Science ®Google Scholar
• Panzer S, Höcker L, Rieger M, Vormittag R, Koren D, Dunkler D, Pabinger I. Agonist-inducible platelet activation in chronic idiopathic autoimmune thrombocytopenia. Eur J Haematol 2007;79:198–204
   PubMed Web of Science ®Google Scholar
• Cines DB, Blanchette VS. Immune thrombocytopenic purpura. N Engl J Med 2002;346:995–1008
   PubMed Web of Science ®Google Scholar
• Cooper N, Bussel J. The pathogenesis of immune thrombocytopaenic purpura. J Br Haematol 2006;133:364–374
   PubMed Web of Science ®Google Scholar
• Severinsen MT, Engebjerg MC, Farkas DK, Jensen AØ, Nørgaard M, Zhao S, Sørensen HT. Risk of venous thromboembolism in patients with primary chronic immune thrombocytopenia: A Danish population-based cohort study. Br J Haematol 2011;152:360–362
   PubMedGoogle Scholar
• Sarpatwari A, Bennett D, Logie JW, Shukla A, Beach KJ, Newland AC, Sanderson S, Provan D. Thromboembolic events among adult patients with primary immune thrombocytopenia in the United Kingdom General Practice Research Database. Haematologica 2010;95:1167–1175
   PubMed Web of Science ®Google Scholar
• Panzer S, Höcker L, Vormittag R, Rieger M, Koren D, Dunkler D, Pabinger I. Flow cytometric evaluation of platelet activation in chronic autoimmune thrombocytopenia. Pediatr Blood Cancer 2006;47:694–696
   Google Scholar
• Cahill MR, Macey MG, Cavenagh JD, Newland AC. Protein A immunoadsorption in chronic refractory ITP reverses increased platelet activation but fails to achieve sustained clinical benefit. Br J Haematol 1998;100:358–364
   PubMed Web of Science ®Google Scholar
• Psaila B, Bussel JB, Linden MD. In vivo effects of eltrombopag on platelet function in immune thrombocytopenia: no evidence of platelet activation. Blood 2012;119:4066–4072
   PubMed Web of Science ®Google Scholar
• Mizutani H, Furubayashi T, Imai Y, Kashiwagi H, Honda S, Take H, Kurata Y, Yonezawa T, Tarui S, Ikehara S. Mechanisms of corticosteroid action in immune thrombocytopenic purpura (ITP): Experimental studies using ITP-prone mice, (NZW × BXSB) F1. Blood 1992;79:942–947
   PubMed Web of Science ®Google Scholar
• Liu XG, Ma SH, Sun JZ, Ren J, Shi Y, Sun L, Dong XY, Qin P, Guo CS, Hou M, Peng J. High-dose dexamethasone shifts the balance of stimulatory and inhibitory Fc gamma receptors on monocytes in patients with primary immune thrombocytopenia. Blood 2011;117:2061–2069
   PubMed Web of Science ®Google Scholar
• Merten M, Thiagarajan P. P-selectin expression on platelets determines size and stability of platelet aggregates. Circulation 2000;102:1931–1936
   PubMed Web of Science ®Google Scholar